Patent 12006298 was granted and assigned to Aldeyra Therapeutics on June, 2024 by the United States Patent and Trademark Office.
The present invention provides freebase and salt forms, and compositions and methods thereof, useful for treating various conditions in which aldehyde toxicity is implicated in the pathogenesis by the administration of small molecule therapeutics acting as a scavenger for toxic aldehydes.